mirtazapine has been researched along with Cancer of Esophagus in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hannon, B | 1 |
| Fitzgerald, P | 1 |
| Murphy, M | 1 |
| Masuzawa, M | 1 |
| Taguchi, H | 1 |
| Sugimoto, T | 1 |
| Kojima, H | 1 |
| Matsumoto, S | 1 |
| Kojima, K | 1 |
| Shingu, K | 1 |
2 other studies available for mirtazapine and Cancer of Esophagus
| Article | Year |
|---|---|
Treatment of depression as part of end-of-life care.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamou | 2008 |
[Case of successful management with mirtazapine for prolonged pain after esophagectomy].
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Esophageal Neoplasms; Esophagectomy; | 2012 |